151 related articles for article (PubMed ID: 34185950)
1. Prevalence of idiopathic hirsutism: A systematic review and meta-analysis.
Amiri M; Fallahzadeh A; Sheidaei A; Mahboobifard F; Ramezani Tehrani F
J Cosmet Dermatol; 2022 Apr; 21(4):1419-1427. PubMed ID: 34185950
[TBL] [Abstract][Full Text] [Related]
2. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
Skiba MA; Islam RM; Bell RJ; Davis SR
Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.
Tehrani FR; Rashidi H; Azizi F
Reprod Biol Endocrinol; 2011 Nov; 9():144. PubMed ID: 22044512
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
7. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and idiopathic hirsutism: A systematic review, meta-analysis, and meta-regression.
Amiri M; Mahmoudieh L; Sheidaei A; Fallahzadeh A; Ramezani Tehrani F
J Cosmet Dermatol; 2022 Nov; 21(11):5346-5359. PubMed ID: 35531788
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.
Tehrani FR; Simbar M; Tohidi M; Hosseinpanah F; Azizi F
Reprod Biol Endocrinol; 2011 Mar; 9():39. PubMed ID: 21435276
[TBL] [Abstract][Full Text] [Related]
11. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Reprod Biol Endocrinol; 2020 Mar; 18(1):23. PubMed ID: 32183820
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
14. The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study.
Sadat Hosseini M; Ramezani Tehrani F; Azizi F
Gynecol Endocrinol; 2013 Sep; 29(9):821-5. PubMed ID: 23782000
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis.
Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi Yarandi R; Saei Ghare Naz M; Carmina E
Gynecol Endocrinol; 2021 May; 37(5):392-405. PubMed ID: 33355023
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
[TBL] [Abstract][Full Text] [Related]
17. The associations of maternal polycystic ovary syndrome and hirsutism with behavioral problems in offspring.
Robinson SL; Ghassabian A; Sundaram R; Trinh MH; Bell EM; Mendola P; Yeung EH
Fertil Steril; 2020 Feb; 113(2):435-443. PubMed ID: 32106995
[TBL] [Abstract][Full Text] [Related]
18. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
[TBL] [Abstract][Full Text] [Related]
19. [Polycystic ovary syndrome: is there a rise in the prevalence?].
Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
[TBL] [Abstract][Full Text] [Related]
20. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
